Dr. Reddy's to release Q3 FY14 results on February 11, 2014

Earnings call slated for February 11, 2014 6.30 PM IST / 8.00 AM EST

HYDERABAD, India--()--Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Third Quarter ended December 31, 2013 on Tuesday, February 11, 2014 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com

Summary of Events

Event     Date and Time (IST)     Medium
Release of financial results     February 11, 2014 after the Board Meeting    

Email, Media, Company website, Business Wire

Earnings Call     February 11, 2014 6.30 PM IST / 8:00 AM EST     Hosted by the Company

(Details below)

Webcast of Earnings Call     February 11, 2014 6.30 PM IST / 8.00 AM EST through February 16, 2014    

URL available on Company’s website,

www.drreddys.com

Transcripts of the Earnings call     Will be available on the Company’s website    

URL available on Company’s website, www.drreddys.com

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.

Conference Dial-In Numbers
Primary Number: +91 22 3065 0136
Secondary Number: +91 22 6629 0356
The numbers listed above are universally accessible from all networks and all countries.
Local Access Number: 6000 1221
Available in - Ahmedabad, Bangalore, Bhubaneswar, Chandigarh, Chennai, Coimbatore, Delhi, Goa, Guntur, Gurgaon, Hyderabad, Indore, Jamshedpur, Kanpur, Kochi/Cochin, Kolhapur, Kolkata, Nagpur, Noida, Patna, Pune, Raipur, Rajkot, Surat, Trivandrum, Vadodara, Vijayawada

Accessible from all major carriers except BSNL/MTNL.

3940 3977

Available in Ahmedabad, Bangalore, Chandigarh, Chennai, Kochi/Cochin, Gurgaon (NCR), Hyderabad, Kolkata, Lucknow, Pune

Accessible from all carriers.

International Toll Free Number: USA: 1 866 746 2133
UK: 0 808 101 1573
Singapore: 800 101 2045
Hong Kong: 800 964 448

No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through February 16, 2014. For play back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's website.

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management and anti-infective. Major markets include India, USA, Russia-CIS and Europe apart from other select geographies within Emerging Markets.

For more information, log on to: www.drreddys.com

Contacts

Investor Relations:
Dr. Reddy's Laboratories
Kedar Upadhye at kedaru@drreddys.com / +91 40 66834297
Saunak Savla at saunaks@drreddys.com / +91 40 49002135
Milan Kalawadia (USA) at mkalawadia@drreddys.com / +1 9082034931

Sharing

Contacts

Investor Relations:
Dr. Reddy's Laboratories
Kedar Upadhye at kedaru@drreddys.com / +91 40 66834297
Saunak Savla at saunaks@drreddys.com / +91 40 49002135
Milan Kalawadia (USA) at mkalawadia@drreddys.com / +1 9082034931